Migraine: Medical Treatments
The question
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of current national clinical arrangements for identifying, recording and acting on patient (a) psychiatric history, (b) psychotropic medication use and (c) previous psychiatric adverse drug reactions prior to the initiation of preventive migraine treatments.
Answered by Preet Kaur Gill
The Department has not made a specific assessment of national arrangements in relation to these issues.
However, we recognise the importance of clinicians having the right information available when considering preventive migraine treatment, including relevant psychiatric history, current medicines, and any previous adverse drug reactions. Prescribers are accountable for their prescribing decisions and should work with patients to decide the most appropriate course of treatment. National Institute for Health and Care Excellence guidance is clear that the choice of preventive treatment should take account of contraindications, comorbidities, and the risk of adverse events. Access to a patient’s full clinical record is therefore important in supporting safe, appropriate, and individualised care.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →